Stephen is a clinical pharmacology consultant. He has worked at Johnson & Johnson/Alza, Inhale Therapeutics, ALZA Corporation, and Merck & Co.
He has participated in the filing of Testoderm, Nicoderm and Duragesics.
Dr. Hwang holds a PhD in Pharmaceutical Chemistry and a master degree (Chemistry) from University of Michigan, Ann Arbor. He obtained his BS degree from Tsing Hua University (Taiwan).